Giuseppe Quero
The Catholic University of America
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Giuseppe Quero.
Medicine | 2016
Giuseppe Quero; Teresa Musarra; Alfredo Carrato; Michelangelo Fici; Maurizio Martini; Angelo Paolo Dei Tos; Sergio Alfieri; Riccardo Ricci
Background: Plexiform angiomyxoid myofibroblastic tumor (PAMT), also known as plexiform fibromyxoma, is a rare distinctive benign intramural tumor, typical of gastric antrum, commonly causing mucosal ulceration with upper gastrointestinal bleeding and anemia, effectively treated by complete surgical resection usually accomplished by distal gastrectomy. Methods and Results: We herein report a 47-year-old man presenting with a syncopal episode, regurgitation and epigastric discomfort, bearing a gastric antral myxoid plexiform tumor positive for &agr;-smooth muscle actin, vimentin and, partially, for caldesmon, desmin, and CD10; CD117, DOG1, CD34, S100, CAM5.2, CK20, CK7, EMA, p53, CDX2, chromogranin A, synaptophysin, anaplastic lymphoma kinase, Melan-A, and HMB-45 were all negative. All these features are typical of PAMT. Of note, focal positivity for AE1/AE3 and pan-CK KL1 was also present. Conclusions: The finding of a focal keratin expression in PAMT contributes to enlarge the immunophenotypic spectrum of this tumor type and is relevant for avoiding presurgical misdiagnoses which could ultimately lead to inappropriate overtreatment of patients with PAMT.
Virchows Archiv | 2018
Gloria Ravegnini; Giuseppe Quero; Giulia Sammarini; Maria Cristina Giustiniani; Federica Castri; Maria Grazia Pomponi; Sabrina Angelini; Sergio Alfieri; Maurizio Genuardi; Giuseppe Zamboni; Riccardo Ricci
The authors regret that the original version of this article, unfortunately, contained an error. The values “1/3 (33%)” reported in the second to last sentence of the Discussion are wrong; the correct values are “2/2 (100%)”. These are presented correctly in this article.
Surgical Innovation | 2018
Sergio Alfieri; Dario Di Miceli; Roberta Menghi; Caterina Cina; Claudio Fiorillo; Francesca Prioli; Fausto Rosa; Giovanni Battista Doglietto; Giuseppe Quero
Purpose. Robotic surgery has gradually gained importance in the treatment of rectal cancer. However, recent studies have not shown any advantages when compared with laparoscopy. The objective of this study is to report a single surgeon’s experience in robotic rectal surgery focusing on short-term and long-term outcomes. Methods. Sixty consecutive robotic rectal resections for adenocarcinoma, over a 4-year period, were retrospectively reviewed. Patients’ characteristics and perioperative outcomes were analyzed. Oncological outcomes and surgical resection quality as well as overall and disease-free survival were also assessed. Results. Thirty patients out of 60 (50%) underwent neoadjuvant therapy. Anterior rectal resection was performed in 52 cases (86.7%), and abdominoperineal resection was done in 8 cases (13.3%). Mean operative time was 283 (±68.6) minutes. The conversion rate was 5% (3 patients). Postoperative complications occurred in 10 cases (16.7%), and reoperation was required in 1 case (1.7%). Mean hospital stay was 9 days, while 30-day mortality was 1.7% (1 patients). The histopathological analysis reported a negative circumferential radial margin and distal margins in 100% of cases with a complete or near complete total mesorectal excision in 98.3% of patients. Mean follow-up was 32.8 months with a recurrence rate of 3.4% (2 patients). Overall survival and disease-free survival were 94% and 87%, respectively. Conclusions. Robotic surgery for rectal cancer proves to be safe and feasible when performed by highly skilled surgeons. It offers acceptable perioperative outcomes with a conversion rate notably lower than with the laparoscopic approach. Adequate pathological results and long-term oncological outcomes were also obtained.
World Journal of Gastroenterology | 2007
Marco Pericoli Ridolfini; Sergio Alfieri; Stavros Gourgiotis; Dario Di Miceli; Fabio Rotondi; Giuseppe Quero; Roberta Manghi; Giovanni Battista Doglietto
Minerva Chirurgica | 2011
Sergio Alfieri; Dario Di Miceli; Roberta Menghi; Giuseppe Quero; Caterina Cina; Giovanni Battista Doglietto; Marco Pericoli Ridolfini
European Review for Medical and Pharmacological Sciences | 2012
Dario Di Miceli; Sergio Alfieri; Patricia Caprino; Roberta Menghi; Giuseppe Quero; Caterina Cina; Marco Pericoli Ridolfini; Giovanni Battista Doglietto
Gastric Cancer | 2017
Claudio Fiorillo; Fausto Rosa; Giuseppe Quero; Roberta Menghi; Giovanni Battista Doglietto; Sergio Alfieri
Il Giornale di chirurgia | 2007
Marco Pericoli Ridolfini; Stavros Gourgiotis; Sergio Alfieri; Dario Di Miceli; Fabio Rotondi; Giuseppe Quero; Futura Limongelli; Alejandro Martin Sanchez; Giovanni Battista Doglietto
JAMA | 2018
Sergio Alfieri; Giuseppe Quero; Amjad Parvaiz
Annals of Surgery | 2018
Fausto Rosa; Giuseppe Quero; Marco Montagna; Sergio Alfieri